P

MDMA

Pharmala Biotech

0.10

0.000.00%
Closed15:59 06/13 EDT

Financial Statements

Statement:

Key indicator

Income Statement

Balance Sheet

Cash Flow

Reporting Period:

Accumulated Report

FY

YoY:
FY: Financial Year Annual Report
Q: Quarter is quarterly reports. Q1, Q2, Q3 and Q4 are reports for a single quarter. Q6 and Q9 are accumulated quarterly reports, respectively contain 6 months' reports and 9 months' report.
Item
FY 2024
FY 2023
FY 2022
FY 2021
Cash from Operating Activities

-321.36K

-339.66K

-625.37K

-173.57K

Net Income

-823.60K

-779.81K

-985.58K

-2.51M

Depreciation/Depletion & Amortization

70.21K

52.77K

12.14K

300

Deferred Taxes

--

--

--

--

Non-Cash Items

829.35K

10.53K

236.53K

2.23M

Changes in Working Capital

-397.33K

376.86K

111.55K

109.00K

Cash from Investing Activities

-226.42K

-506.74K

-994.87K

629.22K

Capital Expenditures

-226.42K

-506.74K

-994.87K

-262.19K

Other Investing Cash Flow Items, Total

--

--

0

891.40K

Cash from Financing Activities

772.12K

189.30K

0

2.02M

Financing Cash Flow Items

697.12K

--

--

--

Total Cash Dividends Paid

--

--

--

--

Issuance (Retirement) of Stock, Net

75.00K

189.30K

0

2.02M

Issuance (Retirement) of Debt, Net

--

--

--

--

Foreign Exchange Effects

--

--

--

--

Net Change in Cash

224.34K

-657.10K

-1.62M

2.47M

Cash Interest Paid

--

--

--

--

Cash Taxes Paid

--

--

--

--